146 related articles for article (PubMed ID: 38710894)
1. QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment.
Shinde A; Panchal K; Patra P; Singh S; Enakolla S; Paliwal R; Chaurasiya A
AAPS PharmSciTech; 2024 May; 25(5):97. PubMed ID: 38710894
[TBL] [Abstract][Full Text] [Related]
2. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
3. Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma.
Deodhar S; Dash AK; North EJ; Hulce M
AAPS PharmSciTech; 2020 Aug; 21(6):231. PubMed ID: 32778980
[TBL] [Abstract][Full Text] [Related]
4. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
5. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
[TBL] [Abstract][Full Text] [Related]
7. Preparation, Characterization, and Anticancer Effects of Capsaicin-Loaded Nanoliposomes.
Al-Samydai A; Alshaer W; Al-Dujaili EAS; Azzam H; Aburjai T
Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836251
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity.
Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Ă–zdemir A; Ark M; Takka S
Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327
[TBL] [Abstract][Full Text] [Related]
9. Tumor RNA-loaded nanoliposomes increases the anti-tumor immune response in colorectal cancer.
Dai D; Yin Y; Hu Y; Lu Y; Zou H; Lu G; Wang Q; Lian J; Gao J; Shen X
Drug Deliv; 2021 Dec; 28(1):1548-1561. PubMed ID: 34286631
[TBL] [Abstract][Full Text] [Related]
10. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z
Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Docetaxel Loading Conditions in Liposomes: proposing potential products for metastatic breast carcinoma chemotherapy.
Vakili-Ghartavol R; Rezayat SM; Faridi-Majidi R; Sadri K; Jaafari MR
Sci Rep; 2020 Mar; 10(1):5569. PubMed ID: 32221371
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and
Zare Kazemabadi F; Heydarinasab A; Akbarzadeh A; Ardjmand M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3222-3230. PubMed ID: 31373225
[No Abstract] [Full Text] [Related]
13. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine.
Xu H; Li Y; Paxton JW; Wu Z
Pharm Res; 2021 Jul; 38(7):1209-1219. PubMed ID: 34189639
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL
Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.
Kumar R; Knick VB; Rudolph SK; Johnson JH; Crosby RM; Crouthamel MC; Hopper TM; Miller CG; Harrington LE; Onori JA; Mullin RJ; Gilmer TM; Truesdale AT; Epperly AH; Boloor A; Stafford JA; Luttrell DK; Cheung M
Mol Cancer Ther; 2007 Jul; 6(7):2012-21. PubMed ID: 17620431
[TBL] [Abstract][Full Text] [Related]
16. Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.
Gholizadeh S; Dolman EM; Wieriks R; Sparidans RW; Hennink WE; Kok RJ
Pharm Res; 2018 Mar; 35(4):85. PubMed ID: 29516187
[TBL] [Abstract][Full Text] [Related]
17. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
18. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Mattheolabakis G; Nie T; Constantinides PP; Rigas B
Pharm Res; 2012 Jun; 29(6):1435-43. PubMed ID: 22072052
[TBL] [Abstract][Full Text] [Related]
19. Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond.
Manjappa AS; Goel PN; Vekataraju MP; Rajesh KS; Makwana K; Ukawala M; Nikam Y; Gude RP; Murthy RS
Pharm Res; 2013 Oct; 30(10):2675-93. PubMed ID: 23756759
[TBL] [Abstract][Full Text] [Related]
20. Preparation, optimization, and characterization of topotecan loaded PEGylated liposomes using factorial design.
Vali AM; Toliyat T; Shafaghi B; Dadashzadeh S
Drug Dev Ind Pharm; 2008 Jan; 34(1):10-23. PubMed ID: 18214751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]